NASDAQ:NVOS

Novo Integrated Sciences Stock Insider Trading

Healthcare > Medical - Care Facilities

Buy NVOS

*Your capital is at risk

$0.0039

+0.0004 (+11.43%)

At Close: Jun 25, 2026

Novo Integrated Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 7.07M and sold 314.31K NVOS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	7.07M shares
● Sell	314.31K shares
65% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 31, 2023 Buy	Stock Option (right to buy) A-Award	David Christopher Mehlin COO & President	CEO / President	2 000 000 Value: $264.0K
May 31, 2023 Buy	Stock Option (right to buy) A-Award	David Christopher Mehlin COO & President	CEO / President	2 000 000 Value: $264.0K
Aug 09, 2022 Buy	Stock Option (right to buy) A-Award	Ali Sarfaraz	Director	39 480 Value: $0
Aug 09, 2022 Buy	Stock Option (right to buy) A-Award	Ali Sarfaraz	Director	39 480 Value: $0
Jun 30, 2022 Buy	Common Stock J-Other	Ali Sarfaraz	Director	0 Value: $0
Jun 30, 2022 Buy	Common Stock J-Other	Ali Sarfaraz	Director	0 Value: $0
Apr 19, 2022 Buy	Common Stock P-Purchase	Oliva Robert Letterio	Director	300 Value: $675
Apr 19, 2022 Buy	Common Stock P-Purchase	Oliva Robert Letterio	Director	300 Value: $675
Feb 23, 2022 Buy	Stock Option (right to buy) A-Award	Oliva Robert Letterio Director	Director	93 995 Value: $125.0K
Feb 23, 2022 Buy	Stock Option (right to buy) A-Award	Flesias Alex Director	Director	93 995 Value: $125.0K
Feb 23, 2022 Buy	Stock option(right to buy) A-Award	Pope Michael Ross Director	Director	93 995 Value: $125.0K
Feb 23, 2022 Buy	Stock Option (right to buy) A-Award	Oliva Robert Letterio Director	Director	93 995 Value: $125.0K
Feb 23, 2022 Buy	Stock Option (right to buy) A-Award	Flesias Alex Director	Director	93 995 Value: $125.0K
Feb 23, 2022 Buy	Stock option(right to buy) A-Award	Pope Michael Ross Director	Director	93 995 Value: $125.0K
Apr 21, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	13 000 Value: $27.6K
Apr 21, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	13 000 Value: $27.6K
Apr 20, 2021 Buy	Common Stock J-Other	Jimenez Sterling M. Officer	Officer	0 Value: $0
Apr 20, 2021 Buy	Common Stock J-Other	Jimenez Sterling M. Officer	Officer	0 Value: $0
Feb 23, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	200 Value: $890
Feb 23, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	200 Value: $890
Feb 22, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	9 355 Value: $40.3K
Feb 22, 2021 Buy	Common Stock P-Purchase	Oliva Robert Letterio Director	Director	9 355 Value: $40.3K
Feb 19, 2021 Buy	Common Stock J-Other	Bray Thomas Edward Officer	Officer	0 Value: $0
Feb 19, 2021 Buy	Common Stock J-Other	Bray Thomas Edward Officer	Officer	0 Value: $0
Feb 19, 2021 Buy	Common Stock	Oliva Robert Letterio Director	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVO INTEGRATED SCIENCES, INC.

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain...

Read Full Profile Here